Review
Aug 2026
Progress and challenges in the design and development of selective KRAS G12D-targeted drug discovery: inhibitors, degraders and emerging therapeutic strategies.
This review summarizes recent progress in KRAS G12D-targeted inhibitors and degraders, highlighting current challenges and future opportunities for improving KRAS-directed cancer treatment.
Eun-Hyoung Jeon, Jaewon Song, Taebo Sim
· Future Medicinal Chemistry · 0 citations